Skip to main content
TipRanks
Go Ultimate75% OFF

Sino Biopharmaceutical (SMZ1) Stock Statistics & Valuation Metrics

0 Followers

Total Valuation

Sino Biopharmaceutical has a market cap or net worth of CHF 10.41B. The enterprise value is CHF 83.38B.

Market Cap
CHF 10.41B
Enterprise Value
CHF 83.38B

Share Statistics

Sino Biopharmaceutical has 18,682,953,000 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
18,682,953,000
Owned by Insiders
15.79%
Owned by Institutions
9.03%

Financial Efficiency

Sino Biopharmaceutical’s return on equity (ROE) is 0.08 and return on invested capital (ROIC) is 8.98%.

Return on Equity (ROE)
0.08
Return on Assets (ROA)
0.03
Return on Invested Capital (ROIC)
8.98%
Return on Capital Employed (ROCE)
0.14
Revenue Per Employee
1.39M
Profits Per Employee
102.61K
Employee Count
22,838
Asset Turnover
0.42
Inventory Turnover
2.53

Valuation Ratios

The current PE Ratio of Sino Biopharmaceutical is 34.61. Sino Biopharmaceutical’s PEG ratio is -0.85.

PE Ratio
34.61
PS Ratio
2.43
PB Ratio
2.55
Price to FCF
15.86
Price to Operating Cash Flow
13.55
PEG Ratio
-0.85

Income Statement

In the last 12 months, Sino Biopharmaceutical had revenue of 31.83B and earned 2.34B in profits. Earnings per share was 0.13.

Revenue
31.83B
Gross Profit
26.13B
Operating Income
6.95B
Pretax Income
6.94B
Net Income
2.34B
EBITDA
7.50B
Earnings Per Share (EPS)
0.13

Cash Flow

In the last 12 months, operating cash flow was 6.13B and capital expenditures -967.92M, giving a free cash flow of 5.16B billion.

Operating Cash Flow
6.13B
Free Cash Flow
5.16B
Free Cash Flow per Share
0.29

Dividends & Yields

Sino Biopharmaceutical pays an annual dividend of ―, resulting in a dividend yield of 1.89%

Dividend Per Share
―
Dividend Yield
1.89%
Payout Ratio
N/A
Free Cash Flow Yield
6.31%
Earnings Yield
2.88%

Stock Price Statistics

Beta
-0.67
52-Week Price Change
9.23%
50-Day Moving Average
0.56
200-Day Moving Average
0.54
Relative Strength Index (RSI)
54.87
Average Volume (3m)
―

Important Dates

Sino Biopharmaceutical upcoming earnings date is Apr 01, 2027, TBA (Not Confirmed).

Last Earnings Date
Aug 19, 2026
Next Earnings Date
Apr 01, 2027
Ex-Dividend Date
―

Financial Position

Sino Biopharmaceutical as a current ratio of 1.37, with Debt / Equity ratio of 52.39%

Current Ratio
1.37
Quick Ratio
1.28
Debt to Market Cap
0.16
Net Debt to EBITDA
0.52
Interest Coverage Ratio
25.65

Taxes

In the past 12 months, Sino Biopharmaceutical has paid 1.63B in taxes.

Income Tax
1.63B
Effective Tax Rate
0.23

Enterprise Valuation

Sino Biopharmaceutical EV to EBITDA ratio is 7.88, with an EV/FCF ratio of 16.29.

EV to Sales
2.50
EV to EBITDA
7.88
EV to Free Cash Flow
16.29
EV to Operating Cash Flow
13.72

Balance Sheet

Sino Biopharmaceutical has CHF 27.58B in cash and marketable securities with CHF 17.17B in debt, giving a net cash position of CHF 10.41B billion.

Cash & Marketable Securities
CHF 27.58B
Total Debt
CHF 17.17B
Net Cash
CHF 10.41B
Net Cash Per Share
CHF 0.56
Tangible Book Value Per Share
CHF 2.11

Margins

Gross margin is 82.43%, with operating margin of 29.76%, and net profit margin of 7.09%.

Gross Margin
82.43%
Operating Margin
29.76%
Pretax Margin
24.67%
Net Profit Margin
7.09%
EBITDA Margin
31.68%
EBIT Margin
28.17%

Analyst Forecast

The average price target for Sino Biopharmaceutical is CHF 0.97, which is 11.43% higher than the current price. The consensus rating is Strong Buy

Price Target
CHF 0.97
Price Target Upside
71.00% Upside
Analyst Consensus
Strong Buy
Analyst Count
9
Revenue Growth Forecast
4.45%
EPS Growth Forecast
-38.06%

Scores

Smart Score
5
AI Score
―